Wird geladen...
Rofecoxib Attenuates the Pathogenesis of Amyotrophic Lateral Sclerosis by Alleviating Cyclooxygenase-2-Mediated Mechanisms
Cyclooxygenase-2 (COX-2) is reported to be activated during the course of amyotrophic lateral sclerosis (ALS) development and progression. However, the roles of COX-2 in aggravating ALS and the underlying mechanism have been largely overlooked. To reveal the mechanisms, the canonical SOD1G93A mouse...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
Frontiers Media S.A.
2020-08-01
|
Schriftenreihe: | Frontiers in Neuroscience |
Schlagworte: | |
Online Zugang: | https://www.frontiersin.org/article/10.3389/fnins.2020.00817/full |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|